These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 6984758

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The selectivity of the anorectic effect of satietin. III. The ineffectiveness of satietin on metabolic rate, body temperature and blood pressure.
    Timár J, Knoll J.
    Pol J Pharmacol Pharm; 1982; 34(1-3):33-9. PubMed ID: 7167421
    [Abstract] [Full Text] [Related]

  • 3. The selectivity of the anorectic effect of satietin. I. The ineffectiveness of satietin on behavioral tests.
    Knoll B, Knoll J.
    Pol J Pharmacol Pharm; 1982; 34(1-3):17-23. PubMed ID: 7167418
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Satietin, a blood-borne, highly selective and potent anorectic glycoprotein.
    Knoll J.
    Biomed Biochim Acta; 1985; 44(2):317-28. PubMed ID: 3890846
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Satietin, a blood-borne anorectic glycoprotein, as the putative rate-limiting satiety signal in the negative feed-back of food intake.
    Knoll J.
    Z Ernahrungswiss; 1984 Jun; 23(2):85-103. PubMed ID: 6475142
    [Abstract] [Full Text] [Related]

  • 10. Satietin; a 50,000 dalton glycoprotein in human serum with potent, long-lasting and selective anorectic activity.
    Knoll J.
    J Neural Transm; 1984 Jun; 59(3):163-94. PubMed ID: 6376708
    [Abstract] [Full Text] [Related]

  • 11. Satietin: Fos mapping of putative brain sites of action.
    Rowland NE, Bellinger LL, Li BH, Mendel VE.
    Brain Res; 1996 Apr 22; 717(1-2):189-92. PubMed ID: 8738271
    [Abstract] [Full Text] [Related]

  • 12. [On the analgesic effect of anorectic substances].
    Moormann J, Opitz K.
    Arzneimittelforschung; 1967 Mar 22; 17(3):343-5. PubMed ID: 5631223
    [No Abstract] [Full Text] [Related]

  • 13. [Behavior of blood pressure during chronic effect of phenylalkylamines].
    Kemper F.
    Arzneimittelforschung; 1969 Oct 22; 19(10):1702-4. PubMed ID: 5395371
    [No Abstract] [Full Text] [Related]

  • 14. Effects of anorectic agents in rats bearing the Walker-256 tumor.
    Maickel RP, Johnson K, Kinney DR.
    Res Commun Chem Pathol Pharmacol; 1987 Dec 22; 58(3):421-4. PubMed ID: 3438577
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of various anorexigenic agents on open field behavior of rats.
    Maickel RP, Johnson SA.
    Res Commun Chem Pathol Pharmacol; 1973 Sep 22; 6(2):733-9. PubMed ID: 4750110
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine.
    Samanin R, Ghezzi D, Valzelli L, Garattini S.
    Eur J Pharmacol; 1972 Sep 22; 19(3):318-22. PubMed ID: 4640855
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the time course of the anorectic effect of fenfluramine and amphetamine with drug levels in blood.
    Blundell JE, Campbell DB, Lesham M, Tozer R.
    J Pharm Pharmacol; 1975 Mar 22; 27(3):187-92. PubMed ID: 238002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.